Skip to main content
. Author manuscript; available in PMC: 2006 Mar 17.
Published in final edited form as: Health Aff (Millwood). 2006;25(1):248–255. doi: 10.1377/hlthaff.25.1.248

EXHIBIT 3.

Mean Annual Out-Of-Pocket Drug Costs Before And After The Implementation Of The MMA Standard Medicare Drug Benefit

Annual out-of-pocket drug costs
Pre- MMA Post- MMA Absolute difference Adjusted differencea(95% CI)
Total $1,192 $ 966 $226
Race/ethnicity
 Hispanic 1,018 843 175 –142 (–265, –19)
 African American 1,050 872 178 –106 (–238, 27)
 White 1,212 979 233 Reference
Household income
 <$21,450 1,375 1,008 367b 72 (–52, 197)
 $21,451–$34,289 1,259 1,051 208 8 (–99, 115)
 $34,290–$55,285 1,122 951 171 –14 (–127, 100)
 >$55,285 976 825 151 Reference
Insurance coverage
 No supplemental coverage 1,345 884 461 Reference
 Employer sponsored 857 989 –132b –576 (–664, –489)
 Self-purchased 1,540 1,041 499 20 (–89, 128)
Chronic conditions
 0 445 347 98 Reference
 1 959 764 195b 84 (21, 147)
 2 1,403 1,173 230b 135 (59, 210)
 3 or more 2,191 1,774 417b 332 (197, 468)

SOURCE: Authors’ analysis of data from the Medical Expenditure Panel Survey, 1996–2000.

NOTES: Data for Asians and other groups are not presented because of small sample sizes. CI is confidence interval.

a

Adjusted difference represents savings with the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 after adjusting for other variables in the model. Savings are compared with the reference group, and a positive number therefore represents more savings, and a negative number represents smaller savings, than the reference group.

b

p < .05 for absolute difference compared with reference group.